Trial Profile
Clinical Trials Insight: 700036622
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2008
Price :
$35
*
At a glance
- Drugs KRP 104 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Kyorin Pharmaceutical
- 26 Aug 2008 New trial record.